The North America Sleep Apnea Devices Market is Expected to Reach $13.5 Billion in 2019- A Report by MicroMarket Monitor

The sleep apnea devices market is marked by a high degree of competition. There are a few well-established firms and several small firms that operate in this industry. Agreements, mergers and acquisitions, partnerships, and collaborations form an important strategy to enhance the bottom line of the key players in this market. 17.0% of the companies channelize their efforts in coalitions, including M&As.
Browse through the TOC of North America Sleep Apnea Devices Market for an analysis of industry trends and segments, with the help of various tables and figures.
For instance, in September 2014, ResMed (U.S.) expanded its agreement with Brightree, the leading provider of home medical equipment (HME) billing and business management software solutions. This expansion is expected to enhance the existing integration of ResMed’s U-Sleep premium sleep compliance solution within the Brightree solution, and thus more features would be added from ResMed’s AirView patient management system. Thus, a cost-effective solution for the HME providers is produced.
Further details & inquiry of this report @
Furthermore, in August 2012, ResMed (U.S.) acquired Umbian Inc., an innovative data services technology provider, which offers a comprehensive patient compliance management solution called U-Sleep, which monitors continuous positive airway pressure (CPAP) devices, and provides a suite of interactive follow-up services for healthcare providers. This acquisition aided the company to capitalize on Umbian, Inc.’s available resources (product mix) to gain a competitive edge in the PAP devices market.
Speak to Analyst @
The sleep apnea devices market is primarily driven by technology and innovations; thus, most of the major players in this market, nearly 63.0%, resort to new product launches, product developments, and new technology launches as important strategies to gain a leadership position in this market. For instance, in August 2014, ResMed (U.S.) released new Air Solutions, for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. It involves compliance management and patient engagement.
Furthermore, in April 2013, Philips Respironics (Netherlands) launched the SleepMapper self-management system, a robust mobile and web-based solution for Obstructive Sleep Apnea (OSA) patients. As a solution to improve the quality of life, the new technology would enhance the quality of the sleep therapy experience.
Related Report:
European Sleep Apnea Devices
The European Sleep Apnea Devices market has been on a rise as a consequence of elevated level of awareness of Sleep Apnea. The market is clinched at $2.5 billion in 2013 and is expected to reach a value of $5.3 billion in 2018, with a CAGR of 15.9% from 2013-2018. The market has been segmented on the basis of Products, Geographies, Endusers, Companies and Macroindicator. Deep dive analysis of the key players have been considered in this report.
Report Subscription:
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at